Handout: Illegal ingredients linked to knockoff weight loss drugs pouring in from foreign sources

Compounded versions of GLP-1 injectable treatments for diabetes and obesity have surged in popularity despite a lack the safety and efficacy assurances. The FDA has warned that these knockoff versions sometimes contain illicit semaglutide or tirzepatide—the active pharmaceutical ingredients (APIs) in weight loss drugs. Working with George Karavetsos, former director of FDA’s Office of Criminal…

[...]

Handout: What is an Alternative Funding Program?

Some employers are hiring consultants, sometimes called “Alternative Funding Program (AFP) vendors” or
“importation program vendors,” to supply employees and their families with illegally imported and unsafe
medicines.

[...]

Five years of PDABs: broken promises, rising costs, and risks to access

Five years of PDABs: broken promises, rising costs, and risks to access (January 2025) Prescription Drug Affordability Boards (PDABs) have been created in several states with the goal to lower prescription drug costs for patients. One of the oldest, Maryland’s, is five years old, but it has yet to fulfill its promise to lower medicine…

[...]